Am along with many others with you on that one. KEVETRIN is still considered by many as the FLAGSHIP development drug of the company. That "forever" is going to take a little longer in that they are recruiting 3 more participants to finish it up and then there is the time space between the END of PHASE I and the start of the next round. So still lots of patience required still but in that I anyway see it as worth BILLIONS down the road. Also hope they HOLD OFF on any partnerships on KEVETRIN as the further they progress on their own the more they can get.

Not ignoring the other drugs in PHASE trials with are also progressing just that I mainly signed on for KEVETRIN.